Volume 72, Number 18, May 5, 2009
About this course
- Released: 05/04/2009
- Expires: 05/05/2011
Learning Objectives:
Upon completion of the article by Doody et al., the participant should be able to:
• State the percentage of patients with MCI with an ApoE4 genotype
• Identify the test score that showed significant improvement for patients who took donepezil for 48 weeks
• State the percentage of patients with muscle spasms as a side effect
Core Competencies:
The article by Doody et al. covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Di Lorenzo et al., the participant should be able to:
• State the percentage of patients with mitochondrial DNA (mtDNA) haplogroup H responding to riboflavin treatment for migraine
• State the odds ratio for a patient in haplogroup H responding to treatment with riboflavin
• State the only factor found to independently predict treatment response to riboflavin
Core Competencies:
The article by Di Lorenzo et al. covers the following core competency:
• Medical Knowledge
Author Disclosures: Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
